125 related articles for article (PubMed ID: 34745507)
1. Human Glioma Cells Therapy Using ATRA-Induced Differentiation Method to Promote the Inhibitive Effect of TMZ and CCDP.
Li X; Zou Z; Ma E; Feng S; Han S
J Healthc Eng; 2021; 2021():6717582. PubMed ID: 34745507
[TBL] [Abstract][Full Text] [Related]
2. Preliminary Study on Relationship Between Temozolomide Chemotherapy-Resistant Cells and Stem Cells in Gliomas.
Min X; Dingchao X; Xun Z; Cunzu W
Turk Neurosurg; 2022; 32(3):357-363. PubMed ID: 35615767
[TBL] [Abstract][Full Text] [Related]
3. PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.
Liu N; Hu G; Wang H; Li Z; Guo Z
J Cell Mol Med; 2018 Nov; 22(11):5300-5310. PubMed ID: 30133120
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
5. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.
Qiu ZK; Shen D; Chen YS; Yang QY; Guo CC; Feng BH; Chen ZP
Chin J Cancer; 2014 Feb; 33(2):115-22. PubMed ID: 23958055
[TBL] [Abstract][Full Text] [Related]
6. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
Gong X; Schwartz PH; Linskey ME; Bota DA
Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
[TBL] [Abstract][Full Text] [Related]
7. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S
Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446
[TBL] [Abstract][Full Text] [Related]
8. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
9. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma.
Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L
Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586
[TBL] [Abstract][Full Text] [Related]
10. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
[TBL] [Abstract][Full Text] [Related]
11. Effect of all-trans retinoic acid on the differentiation of U87 glioma stem/progenitor cells.
Shi Z; Lou M; Zhao Y; Zhang Q; Cui D; Wang K
Cell Mol Neurobiol; 2013 Oct; 33(7):943-51. PubMed ID: 23852377
[TBL] [Abstract][Full Text] [Related]
12. TRPML2 Mucolipin Channels Drive the Response of Glioma Stem Cells to Temozolomide and Affect the Overall Survival in Glioblastoma Patients.
Morelli MB; Nabissi M; Amantini C; Maggi F; Ricci-Vitiani L; Pallini R; Santoni G
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499683
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
14. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Fadera S; Chen PY; Liu HL; Lee IC
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
[TBL] [Abstract][Full Text] [Related]
15. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
[TBL] [Abstract][Full Text] [Related]
16. Role of COL6A2 in malignant progression and temozolomide resistance of glioma.
Hong X; Zhang J; Zou J; Ouyang J; Xiao B; Wang P; Peng X
Cell Signal; 2023 Feb; 102():110560. PubMed ID: 36521657
[TBL] [Abstract][Full Text] [Related]
17. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.
Liu J; Zhang Y; Sun S; Zhang G; Jiang K; Sun P; Zhang Y; Yao B; Sui R; Chen Y; Guo X; Tang T; Shi J; Liang H; Piao H
Oncol Res; 2019 Mar; 27(4):475-486. PubMed ID: 29793559
[TBL] [Abstract][Full Text] [Related]
18. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
[TBL] [Abstract][Full Text] [Related]
19. Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma.
Yuan Y; Yan Z; Miao J; Cai R; Zhang M; Wang Y; Wang L; Dang W; Wang D; Xiang D; Wang Y; Zhang P; Cui Y; Bian X; Ma Q
Stem Cell Res Ther; 2019 Nov; 10(1):330. PubMed ID: 31747975
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells.
Yu Z; Zhao G; Li P; Li Y; Zhou G; Chen Y; Xie G
Oncol Lett; 2016 Apr; 11(4):2792-2800. PubMed ID: 27073554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
